Shimpei Gotoh

4.6k total citations · 2 hit papers
46 papers, 3.3k citations indexed

About

Shimpei Gotoh is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shimpei Gotoh has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Shimpei Gotoh's work include Neonatal Respiratory Health Research (18 papers), Cystic Fibrosis Research Advances (8 papers) and Renal and related cancers (8 papers). Shimpei Gotoh is often cited by papers focused on Neonatal Respiratory Health Research (18 papers), Cystic Fibrosis Research Advances (8 papers) and Renal and related cancers (8 papers). Shimpei Gotoh collaborates with scholars based in Japan, United States and India. Shimpei Gotoh's co-authors include Mikio Furuse, Shöichiro Tsukita, Yoshiteru Seo, Masaki Hata, Nobuo Hashimoto, Hiroyuki Sasaki, Toyohiro Hirai, Akiko Takasuga, Yasuo Tano and Y. Korogi and has published in prestigious journals such as Science, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Shimpei Gotoh

42 papers receiving 3.2k citations

Hit Papers

Size-selective loosening of the blood-brain barrier in cl... 2003 2026 2010 2018 2003 2021 400 800 1.2k

Peers

Shimpei Gotoh
Shimpei Gotoh
Citations per year, relative to Shimpei Gotoh Shimpei Gotoh (= 1×) peers Elisabeth Raschperger

Countries citing papers authored by Shimpei Gotoh

Since Specialization
Citations

This map shows the geographic impact of Shimpei Gotoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimpei Gotoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimpei Gotoh more than expected).

Fields of papers citing papers by Shimpei Gotoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shimpei Gotoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimpei Gotoh. The network helps show where Shimpei Gotoh may publish in the future.

Co-authorship network of co-authors of Shimpei Gotoh

This figure shows the co-authorship network connecting the top 25 collaborators of Shimpei Gotoh. A scholar is included among the top collaborators of Shimpei Gotoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shimpei Gotoh. Shimpei Gotoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Senye, Yukiko Muramoto, Ryuta Mikawa, et al.. (2025). Isogenic induced-pluripotent-stem-cell-derived airway- and alveolus-on-chip models reveal specific innate immune responses. Nature Biomedical Engineering. 9(12). 2028–2042. 2 indexed citations
2.
Sone, Naoyuki & Shimpei Gotoh. (2025). Micro-physiological system of human lung: The current status and application to drug discovery. Drug Metabolism and Pharmacokinetics. 60. 101050–101050.
3.
Xu, Yifei, Tsubasa Matsumoto, Hiroshi Sakaida, et al.. (2024). Two Pediatric Cases of Primary Ciliary Dyskinesia Caused by Loss‐of‐Function Variants in Oral‐Facial‐Digital Syndrome Gene, OFD1. SHILAP Revista de lepidopterología. 2024(1). 1595717–1595717. 1 indexed citations
4.
Hashizume, Ryotaro, Yifei Xu, Makoto Ikejiri, Shimpei Gotoh, & Kazuhiko Takeuchi. (2024). A 3000-year-old founder variant in the DRC1 gene causes primary ciliary dyskinesia in Japan and Korea. Journal of Human Genetics. 69(12). 655–661.
5.
Hashimoto, Rina, Yasufumi Matsumura, Takuya Yamamoto, et al.. (2024). Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants. Stem Cell Reports. 19(4). 545–561. 3 indexed citations
6.
Mikawa, Ryuta, et al.. (2024). Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells. Stem Cell Reports. 19(4). 529–544. 8 indexed citations
7.
Sakai, Kouji, Mandy Siu Yu Lung, Tomoko Matsumoto, et al.. (2023). ACE2 knockout hinders SARS-CoV-2 propagation in iPS cell-derived airway and alveolar epithelial cells. Frontiers in Cell and Developmental Biology. 11. 1290876–1290876. 2 indexed citations
8.
Li, Rongbo, Naoyuki Sone, Shimpei Gotoh, Xin Sun, & James S. Hagood. (2023). Contemporary and emerging technologies for research in children's rare and interstitial lung disease. Pediatric Pulmonology. 59(9). 2349–2359. 1 indexed citations
9.
Mikawa, Ryuta, Yukiko Okuno, Tomonari Awaya, et al.. (2023). Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC. iScience. 26(10). 107731–107731. 2 indexed citations
10.
Xu, Yifei, Guofei Feng, Sawako Masuda, et al.. (2023). Characteristic genetic spectrum of primary ciliary dyskinesia in Japanese patients and global ethnic heterogeneity: population-based genomic variation database analysis. Journal of Human Genetics. 68(7). 455–461. 7 indexed citations
11.
Tamai, Koji, Kouji Sakai, Koichi Igura, et al.. (2022). iPSC-derived mesenchymal cells that support alveolar organoid development. Cell Reports Methods. 2(10). 100314–100314. 12 indexed citations
12.
Hirai, Toyohiro, et al.. (2022). Perspectives of future lung toxicology studies using human pluripotent stem cells. Archives of Toxicology. 96(2). 389–402. 10 indexed citations
13.
Sone, Naoyuki, Satoshi Konishi, Koichi Igura, et al.. (2021). Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology. Science Translational Medicine. 13(601). 41 indexed citations
14.
Nakao, Kazuhisa, et al.. (2021). Hydroxypropyl Cyclodextrin Improves Amiodarone-induced Aberrant Lipid Homeostasis of Alveolar Cells. American Journal of Respiratory Cell and Molecular Biology. 64(4). 504–514. 10 indexed citations
15.
Fujita, Hironori, et al.. (2021). The human EDAR 370V/A polymorphism affects tooth root morphology potentially through the modification of a reaction–diffusion system. Scientific Reports. 11(1). 5143–5143. 6 indexed citations
16.
Yin, Xin, Laura Riva, Yuan Pu, et al.. (2020). MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells. SSRN Electronic Journal. 4 indexed citations
17.
Yamamoto, Yuki, Y. Korogi, Toyohiro Hirai, & Shimpei Gotoh. (2020). A method of generating alveolar organoids using human pluripotent stem cells. Methods in cell biology. 159. 115–141. 15 indexed citations
18.
Korogi, Y., Shimpei Gotoh, Satoshi Ikeo, et al.. (2019). In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. Stem Cell Reports. 12(3). 431–440. 70 indexed citations
19.
Gotoh, Shimpei & Naohiko Chohnabayashi. (2009). Infection 57 Years after Plombage. New England Journal of Medicine. 360(23). e29–e29. 1 indexed citations
20.
Gotoh, Shimpei, Naoki Nishimura, Osamu Takahashi, et al.. (2008). Adrenal function in patients with community-acquired pneumonia. European Respiratory Journal. 31(6). 1268–1273. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026